NCT00381589View on ClinicalTrials.gov

Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

June 30, 2008

Conditions
Hypersalivation
Interventions
DRUG

ipratropium bromide 0.03% spray

Trial Locations (1)

M5T 1R8

Centre for Addiction and Mental Health, Toronto

All Listed Sponsors
lead

Centre for Addiction and Mental Health

OTHER

NCT00381589 - Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide | Biotech Hunter | Biotech Hunter